Improve again! TUL ranked 20th in the list of "top 100 enterprises in China's pharmaceutical industr

On the afternoon of August 1, the "top 100 list of China's pharmaceutical industry in 2020" was released at the 2021 (38th) annual national pharmaceutical industry information conference. Zhuhai United Laboratories Co., Ltd. ranked 20th on the top 100 list, it’s up 1 place from last year.

According to the statistics and analysis of China Pharmaceutical Industry Information Center, the overall revenue of China's top 100 pharmaceutical enterprises in 2020 was 901.21 billion yuan, a decrease of 3.1% compared with 929.64 billion yuan last year. In 2020, the operating revenue of TUL was 8.773 billion yuan, a year-on-year increase of 4.5%.

TUL will continue to increase the research and development of biological drugs, improve the core competitiveness of enterprises, and make contributions to the development of China's pharmaceutical industry and people's health.